Data in weight loss Most of the existing empirical data on weight loss with GLP-1 agonists come from studies of individuals who are overweight or obese, with or without type 2 diabetes, rather than from studies using these agents to counteract iatrogenic weight gain
Nothing in the medication compensates for that, and the composition question becomes more consequential at lower total volume, not less
GLP-1 drugs, which suppress appetite and help people feel full, appear to hamper activation of the brain's reward pathways
Stay Active: Incorporate regular physical activity for better outcomes
We always recommend consulting your provider, but our supplements are meant to complement, not conflict with, your GLP-1 therapy
Some compounding pharmacies offer tirzepatide without B12 as a separate option